CN101537157A - Chinese medicine for treating esophagus cancer - Google Patents

Chinese medicine for treating esophagus cancer Download PDF

Info

Publication number
CN101537157A
CN101537157A CN200810102184A CN200810102184A CN101537157A CN 101537157 A CN101537157 A CN 101537157A CN 200810102184 A CN200810102184 A CN 200810102184A CN 200810102184 A CN200810102184 A CN 200810102184A CN 101537157 A CN101537157 A CN 101537157A
Authority
CN
China
Prior art keywords
radix
chinese medicine
gram
fine powder
quick response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810102184A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN200810102184A priority Critical patent/CN101537157A/en
Publication of CN101537157A publication Critical patent/CN101537157A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of Chinese medicines for treating tumor, and provides a Chinese medicine for treating esophagus cancer with the aims of good effect and quick response. The Chinese medicine is prepared by radix actinidiae argutae, solanum lyratum, frankincense, panax pseudoginseng, Japanese avens root, romanet grape root, radix curcumae, myrrh, glossy ganoderma, bezoar, angelica, borneol, arisaema cum bile, rhizoma imperatae and other Chinese medicines. The Chinese medicine has the functions of reinforcing the body and consolidating foundation, invigorating vital energy and nourishing blood, promoting blood circulation by removing blood stasis, clearing heat and releasing toxin, and resisting cancer, has good effect and quick response, and has the advantages of significant effect, precise curative effect and quick response.

Description

A kind of Chinese medicine for the treatment of esophageal carcinoma
Technical field
The invention belongs to the field of Chinese medicines of treatment tumor.
Background technology
Three phases is generally experienced in the treatment of esophageal carcinoma: (1) finds to make a definite diagnosis esophageal carcinoma, excision focus; (2) carry out radiotherapy or chemotherapy; (3) antitumor Chinese medicine Drug therapy is accepted in part patient tumors recurrence.There are some problems in present esophageal carcinoma treatment by Chinese herbs aspect: the one, and effect is obvious inadequately, and the 2nd, it is slower to take effect, to such an extent as on one side a large amount of esophageal carcinoma patient accepts treatment by Chinese herbs, Yi Bian cancer metastasis spreads, shortened patient's life time.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of esophageal carcinoma, it is obvious inadequately that it can solve in the past in this type of treatment effect, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, determined curative effect, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of esophageal carcinoma adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Actinidiae Chinensis 0.4-2.8 part Herba Solani Lyrati 0.6-3.6 part Olibanum 0.6-3.6 part
Radix Notoginseng 0.4-2.8 part Radix Gei japonici 0.6-3.6 part Radix vitis romanetii 0.4-2.8 part
Radix Curcumae 0.2-1.9 part Myrrha 0.6-3.6 part Ganoderma 0.5-3 part
Calculus Bovis 0.3-1.8 part Radix Angelicae Sinensis 0.6-3.6 part Borneolum Syntheticum 0.1-0.8 part
Arisaema Cum Bile 3-18 part Rhizoma Imperatae 4-26 part
The Chinese medicine of this treatment esophageal carcinoma is made by following method:
(1) by above-mentioned weight ratio, with Radix Actinidiae Chinensis, Herba Solani Lyrati, Radix Gei japonici, Radix vitis romanetii, all gold, Radix Angelicae Sinensis, Arisaema Cum Bile, Rhizoma Imperatae extract through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Olibanum, Radix Notoginseng, Myrrha, Ganoderma, Calculus Bovis, Borneolum Syntheticum are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, the theory of blood circulation promoting and blood stasis dispelling develops meticulously.Prescription that the present invention intends is the side of typical strengthening vital QI to eliminate pathogenic factors, Ganoderma QI invigorating in the side, the body resistance strengthening and constitution consolidating, tonification the five internal organs; Radix Angelicae Sinensis, Radix Actinidiae Chinensis benefiting QI and nourishing blood are invigorated blood circulation; Olibanum, Myrrha, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; The Borneolum Syntheticum causing resuscitation with aromatic drugs; Calculus Bovis, Herba Solani Lyrati, Radix vitis romanetii, Radix Gei japonici heat-clearing and toxic substances removing are anticancer; Assistant with Radix Curcumae regulate the flow of vital energy, Arisaema Cum Bile reduces phlegm, Rhizoma Imperatae diuresis hemostasis.Make a general survey of full side, all medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, the anticancer merit of heat-clearing and toxic substances removing altogether, and are effective, instant effect, and it is remarkable to have effect, determined curative effect, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Actinidiae Chinensis 90 gram Herba Solani Lyratis 100 gram Olibanums 80 grams
Radix Notoginseng 60 gram Radix Gei japonicis 120 gram Radix vitis romanetiis 90 grams
Radix Curcumae 40 gram Myrrhas 100 kairine sesames 90 grams
Calculus Bovis 60 gram Radix Angelicae Sinensis 120 gram Borneolum Syntheticums 20 grams
Arisaema Cum Bile 50 gram Rhizoma Imperataes 70 grams
Weight in accordance with regulations; with conventional water extraction process Radix Actinidiae Chinensis, Herba Solani Lyrati, Radix Gei japonici, Radix vitis romanetii, Radix Curcumae, Radix Angelicae Sinensis, Arisaema Cum Bile, Rhizoma Imperatae are extracted; make extractum fine powder 238 grams; Olibanum, Radix Notoginseng, Myrrha, Ganoderma, Calculus Bovis, Borneolum Syntheticum are ground into fine powder respectively, mix, stir with the extractum fine powder; make fine particle; the capsule of packing into No. 0 is made 2314 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Actinidiae Chinensis 150 gram Herba Solani Lyratis 250 gram Olibanums 260 grams
Radix Notoginseng 160 gram Radix Gei japonicis 200 gram Radix vitis romanetiis 160 grams
Radix Curcumae 110 gram Myrrhas 260 kairine sesames 180 grams
Calculus Bovis 110 gram Radix Angelicae Sinensis 210 gram Borneolum Syntheticums 55 grams
Arisaema Cum Bile 90 gram Rhizoma Imperataes 160 grams
By above-mentioned same method, make 5323 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Actinidiae Chinensis 280 gram Herba Solani Lyratis 360 gram Olibanums 300 grams
Radix Notoginseng 280 gram Radix Gei japonicis 360 gram Radix vitis romanetiis 280 grams
Radix Curcumae 190 gram Myrrhas 300 kairine sesames 280 grams
Calculus Bovis 180 gram Radix Angelicae Sinensis 320 gram Borneolum Syntheticums 80 grams
Arisaema Cum Bile 180 gram Rhizoma Imperataes 230 grams
By above-mentioned same method, make 7821 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.26 gram.
4, get following prescription (by weight):
1.2 parts of 0.8 part of Olibanums of 0.8 portion of Herba Solani Lyrati of Radix Actinidiae Chinensis
0.8 part of 1.2 parts of Radix vitis romanetii of 1.2 parts of Radix Gei japonicis of Radix Notoginseng
1.2 parts of 1.2 portions of Ganodermas of 0.8 part of Myrrha of Radix Curcumae
0.3 part of 1.5 parts of Borneolum Syntheticum of 0.8 part of Radix Angelicae Sinensis of Calculus Bovis
0.6 part of 0.6 part of Rhizoma Imperatae of Arisaema Cum Bile
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
3 parts of 3.6 parts of Olibanums of 2.5 portions of Herba Solani Lyratis of Radix Actinidiae Chinensis
2.5 parts of 3.6 parts of Radix vitis romanetiis of 2.5 parts of Radix Gei japonicis of Radix Notoginseng
2.5 parts of 3 portions of Ganodermas of 1.8 parts of Myrrhas of Radix Curcumae
0.8 part of 3.6 parts of Borneolum Syntheticum of 1.8 parts of Radix Angelicae Sinensis of Calculus Bovis
2.5 parts of 1.8 parts of Rhizoma Imperataes of Arisaema Cum Bile
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science esophageal carcinoma, through 25 routine clinical observations.Selecting the tcm diagnosis esophageal carcinoma is standard: the upper abdomen distension, health is become thin, and is tired unable, in the check esophaguses such as CT tumor arranged.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 14 examples, women's 11 examples do not have other serious disease, and the age is 43 years old-79 years old, 60.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and limbs are strong, and epigastric discomfort disappears, and esophageal tumor tumor body dwindles, and newborn tumor is not seen at other position.
2, effective: body constitution strengthens, and esophageal tumor tumor body is not seen increase, and newborn tumor is not seen at other position.
3, invalid: the symptom no change, esophageal tumor tumor body increases, or newborn tumor appears in other position.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 7 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom has clear improvement.25 philtrums of clinical experiment, produce effects 10 people, effective 12 people, invalid 3 people, total effective rate 88%.

Claims (1)

1, a kind of Chinese medicine for the treatment of esophageal carcinoma, it is characterized in that: it is made with the weight ratio of following component, and its component proportioning is:
Radix Actinidiae Chinensis 0.4-2.8 part Herba Solani Lyrati 0.6-3.6 part Olibanum 0.6-3.6 part
Radix Notoginseng 0.4-2.8 part Radix Gei japonici 0.6-3.6 part Radix vitis romanetii 0.4-2.8 part
Radix Curcumae 02-1.9 part Myrrha 0.6-3.6 part Ganoderma 0.5-3 part
Calculus Bovis 0.3-1.8 part Radix Angelicae Sinensis 0.6-3.6 part Borneolum Syntheticum 0.1-0.8 part
Arisaema Cum Bile 3-18 part Rhizoma Imperatae 4-26 part
The Chinese medicine of this treatment esophageal carcinoma is made by following method:
(1) by above-mentioned weight ratio, Radix Actinidiae Chinensis, Herba Solani Lyrati, Radix Gei japonici, Radix vitis romanetii, Radix Curcumae, Radix Angelicae Sinensis, Arisaema Cum Bile, Rhizoma Imperatae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Olibanum, Radix Notoginseng, Myrrha, Ganoderma, Calculus Bovis, Borneolum Syntheticum are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
CN200810102184A 2008-03-19 2008-03-19 Chinese medicine for treating esophagus cancer Pending CN101537157A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810102184A CN101537157A (en) 2008-03-19 2008-03-19 Chinese medicine for treating esophagus cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810102184A CN101537157A (en) 2008-03-19 2008-03-19 Chinese medicine for treating esophagus cancer

Publications (1)

Publication Number Publication Date
CN101537157A true CN101537157A (en) 2009-09-23

Family

ID=41120699

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810102184A Pending CN101537157A (en) 2008-03-19 2008-03-19 Chinese medicine for treating esophagus cancer

Country Status (1)

Country Link
CN (1) CN101537157A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784320A (en) * 2015-05-10 2015-07-22 胡荣 Medicine for treating esophageal cancers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784320A (en) * 2015-05-10 2015-07-22 胡荣 Medicine for treating esophageal cancers

Similar Documents

Publication Publication Date Title
CN101537146B (en) Chinese medicine for treating carcinoma of colon
CN101530461B (en) Traditional Chinese medicine for treating nasopharyngeal cancer
CN101879257A (en) Traditional Chinese medicine for treating tumors
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN101406594B (en) Chinese medicine for treating tumor of lung
CN101530508A (en) Traditional Chinese medicine for treating ovarian cancer
CN101406566B (en) Chinese medicine for treating gastric cancer
CN101530490B (en) Traditional Chinese medicine for treating bladder cancer
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101518607B (en) Traditional Chinese medicine for treating carcinoma of kidney
CN102172369A (en) Chinese medicine for treating hepatocirrhosis
CN101537157A (en) Chinese medicine for treating esophagus cancer
CN101537061B (en) Chinese medicine for treating liver cancer
CN102302606A (en) Chinese medicament for treating chronic prostatitis
CN102380037A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101537068B (en) Chinese medicine for treating angina
CN101518633B (en) Traditional Chinese medicine for treating thyroid cancer
CN101554426B (en) Traditional Chinese medicine for treating diabetic obstipation
CN101396454B (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101843717B (en) Chinese medicament for treating coronary disease
CN101518622B (en) Traditional Chinese medicine for treating diabetes complicated with urinary infection
CN101843744B (en) Chinese medicament for treating chronic kidney failure
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN102379992A (en) Chinese medicament for treating diabetic diarrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090923